Fiche du document
27 décembre 2021
- doi: 10.3390/jcm11010132
- issn: 2077-0383
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3390/jcm11010132
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35011871
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2077-0383
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C0AE59CB2EEF0
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Citer ce document
E. Diamanti et al., « Carbon Monoxide Diffusion Capacity as a Severity Marker in Pulmonary Hypertension. », Serveur académique Lausannois, ID : 10.3390/jcm11010132
Métriques
Partage / Export
Résumé
Carbon monoxide diffusion capacity (DLCO) is negatively associated with patient survival in idiopathic pulmonary hypertension (PH), but is not included in the risk stratification score proposed by the 2015 European guidelines. Since 2015, several new stratification scores based on a 3- or 4-severity scale have been explored. This retrospective cohort single-center study sought to investigate the association between DLCO and PH severity and survival. We included 85 treatment-naive patients with precapillary PH and DLCO measurement at diagnosis. DLCO status, based on lower and upper quartiles ranges, was added to a 3- and a 4-strata modified-risk assessment. DLCO was strongly associated with transplant-free survival (HR 0.939, 95% CI: 0.908-0.971, p < 0.001). In the intermediate and high-risk categories, DLCO was associated with transplant-free survival, irrespective of the risk category (HR 0.934, 95% CI: 0.880-0.980, p = 0.005). The correlation between modified-risk category and transplant-free survival was significant (HR 4.60, 95% CI: 1.294-16.352, p = 0.018). Based on the Akaike information criterion (AIC) levels, the 3- and 4-strata modified-risk stratification fits our results better than the conventional stratification. Low DLCO is associated with patient transplant-free survival, independently of the risk category. Inclusion of DLCO into a PH risk stratification score seems promising and needs further investigation.